Skip to content
LEVOFLOXACIN Injection in 5% Dextrose and LEVOFLOXACIN Injection Print E-mail
Levofloxacin
 
LATEX-FREE • PRESERVATIVE-FREE • AP RATED • PVC-FREE* • DEHP-FREE*
 
*Premix bags
 
Brand Name Equivalent: LEVAQUIN®
(LEVAQUIN is a registered trademark of Daiichi Sankyo Company.)		  Electronic Catalog
Therapeutic Category: Anti-Infective / Antibiotic
  • Consider these SAGENT Benefits:
     
  • Available In:
  • • Premix bags
  •   - 250 mg per 50 mL in 5% Dextrose
  •   - 500 mg per 100 mL in 5% Dextrose
  •   - 750 mg per 150 mL in 5% Dextrose
  • • Single-use vials
  •   - 500 mg per 20 mL
  •   - 750 mg per 30 mL
  • • Discover PreventIV MeasuresSM packaging features:
  •   - Easy-to-read drug name and dosage strength
  •   - Bar codes included on the overwrap, bag, vial and carton for ease of scanning
  •   - Unique label design to help products stand out on the shelf
  • • Enhanced packaging and labeling designed to promote safety and help reduce medication errors
  • • Ready to use premix bags facilitate adherence to USP <797>
NDC #25021
 Description Strength Fill Volume Concentration
 Container Size Closure Unit of Sale
 Package Insert Storage Requirements Product Photos 360o View
132-81 Premix Bag 250 mg 50 mL 5 mg per mL N/A N/A 24 Package Insert Package Insert
 Product Photos 360 Product View
132-82 Premix Bag 500 mg 100 mL
 5 mg per mL N/A N/A 24 Package Insert Package Insert
 Product Photos 360 Product View
132-83
 Premix Bag 750 mg
150 mL
 5 mg per mL
 N/A  N/A 24
 Package Insert Storage Requirements
 Product Photos 360 Product View
130-20
 Glass Vial 500 mg
20 mL
 25 mg per mL
 20 mL  20 mm 1
 Package Insert Storage Requirements
 Product Photos 360 Product View
130-30
 Glass Vial 750 mg
30 mL
 25 mg per mL
 30 mL
 20 mm
 1 Package Insert Storage Requirements
 Product Photos 360 Product View

Levofloxacin Catalog Insert    MSDS Sheet (vials)    MSDS Sheet (premix bags)    Bar Codes    Wholesaler Item Numbers
WARNING:
Fluoroquinolones, including LEVOFLOXACIN Injection, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants (see WARNINGS AND PRECAUTIONS).
Fluoroquinolones, including LEVOFLOXACIN Injection may exacerbate muscle weakness in persons with myasthenia gravis. Avoid LEVOFLOXACIN Injection in patients with known history of myasthenia gravis (see WARNINGS AND PRECAUTIONS).
   Please refer to full prescribing information and medication guide.
 

 [Back to Products page]
LATEX-FREE = There is no natural rubber latex in the vial container closure, label adhesive, bag material or port(s) in these SAGENT products.
This product information is intended for U.S. residents only.  All trademarks and registered trademarks are the property of their respective owners.